Experimental evidence from the past years highlights a key role for the intestinal microbiota
in inflammatory and malignant gastrointestinal diseases. Diet exhibits a strong impact on …

Hematologic neoplasms represent 6.5% of all cancers worldwide. They are characterized by
the uncontrolled growth of hematopoietic and lymphoid cells and a decreased immune …

Lung cancer (LC) is one of the most serious malignant tumors, which has the fastest growing
morbidity and mortality worldwide. A role of the lung microbiota in LC pathogenesis has …

The collection of microbes that live in and on the human body–the human microbiome–can
impact on cancer initiation, progression, and response to therapy, including cancer …

Abstract Glycyrrhiza Uralensis Polysaccharide (GCP), as a macromolecular polysaccharide
extracted from the Traditional Chinese Medicine (TCM)-Licorice has been proved to inhibit …

Colorectal cancer (CRC) is a common, and deadly disease. Despite the improved
knowledge on CRC heterogeneity and advances in the medical sciences, there is still an …

Emerging evidence points to a strong association between the bile acid (BA)-gut microbiota
(GM) axis, and the risk of colorectal cancer (CRC). Kaempferol, a common polyphenol in the …

The incidence of the intestinal disease is globally increasing, and the intestinal mucosa
immune system is an important defense line. A potential environmental cause to regulate gut …

Intestinal microbiota is gaining increasing interest from researchers, and a series of studies
proved that gut bacteria plays a significant role in various malignancies, especially in …

Simple Summary The role of the microbiome for the development and treatment of acute
lymphoblastic leukemia (ALL) is not well understood. The immune system and microbiota …